The current biomedical Research and Development (R&D) system serves profits over people. In the last 20 years, various R&D initiatives have appeared in response to this failure. Some offer true alternative models of R&D driven by health needs, while others continue business as usual. UAEM’s RE:Route mapping and data visualization provides a qualitative review of the alternative biomedical R&D initiatives around the world that are active or proposed.
Re:Route aims to engage in a growing collaborative dialogue around the exploration of needs-driven and people-oriented biomedical R&D. It draws attention to what is currently out there and provides a starting point for an ongoing and inclusive dialogue informed by facts. It was included in the UN High Level Panel Report on Access to Medicines in 2016.
Visit UAEM’s Alt:ReRoute microsite, download the mapping and join us in taking this project forward.
R&D Principles and Practices
- We must prioritize the health and wellbeing of people over the drive for profits, and support policies and models of funding that incentivize research to most directly benefit the public;
- Today’s profit-centered model of biomedical R&D has proven ill-suited to address the health needs of all people worldwide;
- To maximize the health impact of biomedical R&D, we need a new approach to R&D that delivers genuine innovation that is accessible and affordable for all, and that is governed by equitable principles and practices;